The sensitivity, accuracy, and precision of the CU compared favorably with those of the CYCLO-Trac SP RIA.
Methadone

Nordexopropoxyphene
Amphetamine Pethidine 70% methan 50% methan 60% methan 60% methanol CLINICALCHEMISTRY, Vol.36, No.6, 1990 909 sweat (1) have led laboratory workers to find ways of reducing the risk of handling specimens from groups at high risk for carrying the virus, e.g.,those who inject drugs.
Inactivation by heating (2) and by the use of bleach or glutaraldehyde is reportedly satisfactory (3). However, the easiest and moat common way of reducing risk in the laboratory is to heat samples. Our laboratory routinely heats such high-risk urine samples at 56#{176}C for 1 h before analysis (4). However, recent work (5) indicates that urine samples with a high initial H1V titer may still be infectious even after heating for more than 3 h at 56#{176}C. Thus higher temperatures may be needed to inactivate H1V. Despite investigation of the effect of heat treatment on results for normal hospital biochemical analysis in plasma and serum (6) and excellent reviews covering many aspects of urinalysis for drugs of abuse (7), there are only sparse reports on heat stability of drugs in urine. These 
Standards.
Benzoylecgonine, amphetamine sulfate, and nordextropropoxyphene were obtained from Sigma Chemical Co. Ltd. (Poole, Dorset, U.K. 
Extraction.
After heating, we adjusted the pH of each treated urine to pH 8.5-9.0 with sodium hydroxide (0.5 mol/L), and centrifuged at 1000 x g for 2 mm at room temperature. The supernates were then extracted on BondElut C18 cartridges as described elsewhere (9). In brief: before use, the cartridges had been primed with 2 mL of methanol, followedby 1 mL of ammonium hydroxide (0.01 mol/L). The urine supernates were transferred to the cartridge reservoirs before the ammonium hydroxide had completely passed through the column. The eluate was then discarded. A small slug of air was allowed to pass through, followed by 1 mL of ammonia solution (0.01 mol/L). The cartridge was then dried by allowing air to be drawn through.
After the column had been dried, 0.5 mL of a methanol:water mixture (see below) was drawn through the cartridge to remove unwanted contaminants. Because the retention of each drug on the C18 Bond-Elut cartridge differed, the clean-up procedure for each drug was varied accordingly. The percentage (by vol) of methanol used for this washing sequence was as follows:
No cartridge-washing step was possible for the assay of benzoylecgonine because the washing procedure effectively removed this polar metabolite from the cartridge. After the wash, the cartridge was dried once again by suction,after which the drug or met.abolite was eluted with 1 mL of methanol. The eluates were then transferred to 1-mL conical vials for immediate analysis by HPLC.
Results and DiscussIon
Figure 1 To test for significance, we calculated the mean value for a given drug undergoing each treatment and performed Student's t-test for correlated data. The results from each form of heat treatment (60, 70, and 100#{176}C) were compared with those for urine left at room temperature. We found that heating at 60 or 70#{176}C did not cause significant destruction of any of the drugs investigated. In some cases-notably pethidine, nordextropropoxyphene, and methadone-low heat at pH 5.1 actually increased the amount of drug detected.
Heating at 100#{176}C did cause a decrease in recovery of all the drugs. Three of the drugs investigated were labile to the 100#{176}C treatment both at pH 5.1 and pH 7.6: benzoylecgomne (P <0.05), pethidine (P <0.05), and amphetamine (P <0.025). The heat-labile drug amphetamine was almost completely lost (Figure 1) . The concentration of nordextropropoxyphene in urine heated at 100#{176}C was significantly decreased only at pH 7.6 (P <0.05), whereas methadone was more labile at pH 5.1.
The results in Figure 1 showthat, rather than decreasing stability, heating at 60 or 70#{176}C sometimes actually increased the amount of some of the drugs detected. This phenomenon may be due to the dissolution of precipitate in urine, which can bind some drugs. Indeed, we found that the usual procedure of thawing, centrifuging, and discarding the precipitate before analysis actually removed a significant proportion of the drug, particularly if the urine was alkaline.
In contrast, heating to 100#{176}C caused some loss of all the drugs tested. Furthermore, the use of such a high temperature defeated the aim of safeguarding the staff, because our polystyrene urine collection tubes (LSL Sales Ltd., Rochdale, U.K.) could not withstand heating to 100#{176}C, so that samples had first to be transferred to glass containers. There was also a tendency for the urine to boil over during this form of treatment.
The only plastic tube we found that would withstand heating at 100#{176}C was a 10-mL polypropylene blood-collection tube (LSL Sales Ltd.). The 20-mL universal tubes we used for the collection of urine were not available in polypropylene.
In conclusion, we found that heat-treating urine samples at 70#{176}C in the containers in which they are received in the laboratory will not destroy drugs of abuse. Even after prolonged heating at this temperature, amphetamine, the most labile of the drugs, would still be easily detected. The results from these small numbers of samples were quite consistent and are sufficient to reassure laboratories undertaking qualitative screening that such heating will not prevent a positive identification. All the plastic polystyrene containers commonly used for the collection of urine samples withstood this temperature without distortion or leakage. Whether heating at 70#{176}C will inactivate HW remains to be determined. Heating to 100 #{176}C is not recommended for urines to be screened for drugs of abuse.
